Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Feb 28, 2005; 11(8): 1187-1192
Published online Feb 28, 2005. doi: 10.3748/wjg.v11.i8.1187
Published online Feb 28, 2005. doi: 10.3748/wjg.v11.i8.1187
Table 1 Genotype frequencies of the IBD5 SNPs in Crohn’s disease patients and controls.
| TT (%) | GT (%) | GG (%) | |
| Controls (n = 511) | 170 (33.3) | 236 (46.2) | 105 (20.5) |
| CD patients (n = 274) | 74 (27) | 136 (49.6) | 64 (23.4) |
| CD-L1 (n = 133) terminal ileum + UG | 41 (30.8) | 66 (49.6) | 26 (19.6) |
| CD-L2 (n = 46) colon | 12 (26.1) | 23 (50) | 11 (23.9) |
| CD-L3 (n = 95) ileocolon | 21 (22.1) | 47 (49.5) | 27 (28.4)a |
| CD-B1 (n = 119) inflammatory | 36 (30.2) | 60 (50.4) | 23 (19.3) |
| CD-B2 (n = 44) stricturing | 14 (31.8) | 22 (50) | 8 (18.2) |
| CD-B3 (n = 110) fistulizing | 24 (21.3) | 53 (48.9) | 33 (30)c |
| CD-perianal (n = 47) | 10 (21.3) | 23 (48.9) | 14 (29.8) |
| CD-non perianal (n = 227) | 64 (28.2) | 113 (49.8) | 50 (22) |
- Citation: Urcelay E, Mendoza JL, Martínez A, Fernández L, Taxonera C, Díaz-Rubio M, de la Concha EG. IBD5 polymorphisms in inflammatory bowel disease: Association with response to infliximab. World J Gastroenterol 2005; 11(8): 1187-1192
- URL: https://www.wjgnet.com/1007-9327/full/v11/i8/1187.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i8.1187